Leptin and the control of obesity

Current Opinion in Pharmacology

Volumn 1, Issue 6, 2001, Pages 656-661

  Wilding, John P H ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Endocrinology; Hypothalamus; Leptin; Neuroscience; Obesity; Pharmacology; Sympathetic nervous system

Indexed keywords

CARRIER PROTEIN; LEPTIN; LEPTIN RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL; BODY WEIGHT; GENETICS; HUMAN; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW;

ANIMAL; BODY WEIGHT; CARRIER PROTEINS; HUMAN; LEPTIN; OBESITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 0035654860     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(01)00111-4     Document Type: Review

References (64)

1. Zhang Y.Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homolog. Nature. 372:1994;425-432.
2. Coleman D.L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia. 9:1973;294-298.
3. Tartaglia L.A., Dembski M., Weng X., Deng N.H., Culpepper J., Devos R., Richards G.J., Campfield L.A., Clark F.T., Deeds J., et al. Identification and expression cloning of a leptin receptor, ob-r. Cell. 83:1995;1263-1271.
4. Khawaja X.Z., Bailey C.J., Green I.C. Central mu, delta, and kappa opioid binding sites, and brain and pituitary beta-endorphin and met-enkephalin in genetically obese (ob/ob) and lean mice. Life Sci. 44:1989;1097-1105.
5. Wilding J.P.H., Gilbey S.G., Bailey C.J., Batt R.A.L., Williams G., Ghatei M.A., Bloom S.R. Increased neuropeptide Y messenger RNA and decreased neurotensin messenger RNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1993;1939-1944.
6. Bailey C.J., Day C., Bray G.A., Lipson L.G., Flatt P.R. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice. Horm Metab Res. 18:1986;357-360.
7. Schwartz M.W., Marks J.L., Sipols A.J., Baskin D.G., Woods S.C., Kahn S.E., Porte D. Central insulin administration reduces neuropeptide-Y messenger RNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 128:1991;2645-2647.
8. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., Mckee L.J., Bauer T.L., Caro J.F. Serum immunoreactive leptin concentrations in normal-weight and obese humans. New Engl J Med. 334:1996;292-295.
9. Rayner D.V., Trayhurn P. Regulation of leptin production: sympathetic nervous system interactions. J Mol Med. 79:2001;8-20. A useful and comprehensive review of the regulation of leptin production.
10. Moreno-Aliaga M.J., Stanhope K.L., Havel P.J. Transcriptional regulation of the leptin promoter by insulin-stimulated glucose metabolism in 3t3-l1 adipocytes. Biochem Biophys Res Commun. 283:2001;544-548.
11. Levy J.R., Gyarmati J., Lesko J.M., Adler R.A., Stevens W. Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway. Am J Physiol Endocrinol Metab. 278:2000;E892-E901.
12. Levy J.R., Stevens W. The effects of insulin, glucose, and pyruvate on the kinetics of leptin secretion. Endocrinology. 142:2001;3558-3562.
13. Wellhoener P., Fruehwald-Schultes B., Kern W., Dantz D., Kerner W., Born J., Fehm H.L., Peters A. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab. 85:2000;1267-1271.
14. Takahashi Y., Ide T. Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr. 84:2000;175-184.
15. Reseland J.E., Haugen F., Hollung K., Solvoll K., Halvorsen B., Brude I.R., Nenseter M.S., Christiansen E.N., Drevon C.A. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res. 42:2001;743-750.
16. Pickavance L., Taddayon M., Widdowson P.S., Buckingham R.E., Wilding J.P.H. Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution and effects on body weight and plasma leptin. Br J Pharmacol. 128:1999;1570-1576.
17. Sinha M.K., Sturis J., Ohannesian J., Magosin S., Stephens T., Heiman M.L., Polonsky K.S., Caro J.F. Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun. 228:1996;733-738.
18. Pinkney J.H., Goodrick S.J., Katz J.R., Johnson A.B., Lightman S.L., Coppack S.W., Medbak S., Mohamed-Ali V. Thyroid and sympathetic influences on plasma leptin in hypothyroidism and hyperthyroidism. Int J Obes Relat Metab Disord. 24:(suppl 2):2000;S165-S166.
19. Ahmad A.M., Guzder R., Wallace A.M., Thomas J., Fraser W.D., Vora J.P. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement. J Clin Endocrinol Metab. 86:2001;3499-3506.
20. Zhang Y., Hufnagel C., Eiden S., Guo K.Y., Diaz P.A., Leibel R., Schmidt I. Mechanisms for LEPR-mediated regulation of leptin expression in brown and white adipocytes in rat pups. Physiol Genomics. 4:2001;189-199.
21. Banks W.A., Kastin A.J., Huang W.T., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides. 17:1996;305-311.
22. Wang Q., Bing C., Al-Barazanji K., Mossakowaska D.E., Wang X., McBay D., Neville W.A., Taddayon M., Pickavance L., Dryden S., et al. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes. 46:1997;335-341.
23. Claycombe K.J., Xue B.Z., Mynatt R.L., Zemel M.B., Moustaid-Moussa N. Regulation of leptin by agouti. Physiol Genomics. 2:2000;101-105.
24. Cowley M.A., Smart J.L., Rubinstein M., Cordan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480-484. This study used an electrophysiological approach to characterise responses to leptin in pro-opiomelanocortin (POMC) neurones identified by selective expression of green fluorescent protein in transgenic mice. The authors were able to demonstrate activation of these cells by leptin, reduced inhibition from local neuropeptide Y and GABAergic neurones and an autoinhibitory effect of melanocortins.
25. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 410:2001;822-825.
26. Sahu A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology. 139:1998;795-798.
27. Wang L., Barachina M.D., Martinez V., Wei J.Y., Tache Y. Synergistic interaction between CCK and leptin to regulate food intake. Regul Pept. 92:2000;79-85.
28. Finn P.D., Cunningham M.J., Rickard D.G., Clifton D.K., Steiner R.A. Serotonergic neurons are targets for leptin in the monkey. J Clin Endocrinol Metab. 86:2001;422-426.
29. Ovesjo M.L., Gamstedt M., Collin M., Meister B. GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J Neuroendocrinol. 13:2001;505-516.
30. Calapai G., Corica F., Allegra A., Corsonello A., Sautebin L., DeGregorio T., DiRosa M., Costantino G., Buemi M., Caputi A.P. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Br J Pharmacol. 125:1998;798-802.
31. Masaki T., Yoshimatsu H., Chiba S., Watanabe T., Sakata T. Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes. 50:2001;385-391.
32. Rosenblum C.I., Tota M., Cully D., Smith T., Collum R., Qureshi S., Hess J.F., Phillips M.S., Hey P.J., Vongs A., et al. Functional STAT-1 and STAT-3 signaling by the leptin receptor (OB-R): reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology. 137:1996;5178-5181.
33. Carvalheira J.B.C., Siloto R.M.P., Ignacchitti I., Brenelli S.L., Carvalho C.R.O., Leite A., Velloso L.A., Gontijo J.A.R., Saad M.J.A. Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett. 500:2001;119-124. An interesting study that explains interactions between leptin and insulin in appetite control at the molecular level.
34. Banks W.A., Clever C.M., Farrell C.L. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol Endocrinol Metab. 278:2000;E1158-E1165.
35. Dhillon H., Kalra S.P., Kalra P.S. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther. 4:2001;139-145.
36. Reaven G.M., Lithel H., Landsberg L. Mechanisms of disease: hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. New Engl J Med. 334:1996;374-381.
37. Haynes W.G. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep. 2:2000;311-318.
38. Tang-Christensen M., Havel P.J., Jacobs R.R., Larsen P.J., Cameron J.L. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab. 84:1999;711-717.
39. Paolisso G., Manzella D., Montano N., Gambardella A., Varricchio M. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab. 85:2000;1810-1814.
40. Mix H., Widjaja A., Jandl O., Cornberg M., Kaul A., Goke M., Beil W., Kuske M., Brabant G., Manns M.P., Wagner S. Expression of leptin and leptin receptor isoforms in the human stomach. Gut. 47:2000;481-486.
41. Reitman M.L., Bi S., Marcus-Samuels B., Gavrilova O. Leptin and its role in pregnancy and fetal development - an overview. Biochem Soc Trans. 29:2001;68-72.
42. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H., Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept. 92:2000;73-78.
43. Reseland J.E., Syversen U., Bakke I., Qvigstad G., Eide L.G., Hjertner O., Gordeladze J.O., Drevon C.A. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res. 16:2001;1426-1433.
44. Karsenty G. Leptin controls bone formation through a hypothalamic relay. Recent Prog Horm Res. 56:2001;401-415.
45. Faggioni R., Moser A., Feingold K.R., Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol. 156:2000;1781-1787.
46. Arnalich F., Lopez J., Codoceo R., Jim nez M., Madero R., Montiel C. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J Infect Dis. 180:1999;908-911.
47. Bornstein S.R., Licinio J., Tauchnitz R., Engelmann L., Negrao A.B., Gold P., Chrousos G.P. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab. 83:1998;280-283.
48. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene-product on body-weight regulation in ob/ob mice. Science. 269:1995;540-543.
49. Surwit R.S., Edwards C.L., Murthy S., Petro A.E. Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes. 49:2000;1203-1208.
50. Ebihara K., Ogawa Y., Masuzaki H., Shintani M., Miyanaga F., Aizawa-Abe M., Hayashi T., Hosoda K., Inoue G., Yoshimasa Y., et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes. 50:2001;1440-1448. AZIPF1 lipoatrophic mice are characterised by having virtually no fat, are markedly insulin resistant and have severe hepatic steatosis. This paper demonstrates that leptin replacement can improve insulin resistance and glucose metabolism in this animal model of lipoatrophic diabetes and could lead to trials of leptin treatment in humans with lipodystrophy.
51. Gavrilova O., Marcus-Samuels B., Leon L.R., Vinson C., Reitman M.L. Leptin and diabetes in lipoatrophic mice. Nature. 403:2000;850-851.
52. Boozer C.N., Leibel R.L., Love R.J., Cha M.C., Aronne L.J. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Metabolism. 50:2001;889-893.
53. Dhillon H., Kalra S.P., Prima V., Zolotukhin S., Scarpace P.J., Moldawer L.L., Muzyczka N., Kalra P.S. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept. 99:2001;69-77. This study used a novel gene therapy approach to leptin administration and successfully prevented weight gain in rats without a genetic defect in leptin production. However, no weight loss was seen and this is consistent with human data.
54. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
55. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J.-M., et al. A mutation in the leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:1998;398-401.
56. Ozata M., Uckaya G., Aydin A., Isimer A., Ozdemir I.C. Defective antioxidant defense system in patients with a human leptin gene mutation. Horm Metab Res. 32:2000;269-272.
57. Farooqi I.S., Jebb S.A., Langmack G., Lawrence E., Cheetham C.H., Prentice A.M., Hughes I.A., McCamish M.A., O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New Engl J Med. 341:1999;879-884.
58. Wauters M., Mertens I., Rankinen T., Chagnon M., Bouchard C., Van Gaal L. Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. J Clin Endocrinol Metab. 86:2001;3227-3232.
59. Clement K., Garner C., Hager J., Philippi A., Leduc C., Carey A., Harris T.J.R., Jury C., Cardon L.R., Basdevant A., et al. Indication for linkage of the human ob gene region with extreme obesity. Diabetes. 45:1996;687-690.
60. Carlsson B., Lindell K., Gabrielsson B., Karlsson C., Bjarnason R., Westphal O., Karlsson U., Sjostrom L., Carlsson L.M.S. Obese (ob) gene defects are rare in human obesity. Obesity Res. 5:1997;30-35.
61. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., Lubina J.A., Patane J., Self B., Hunt P., McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. J Am Med Assoc. 282:1999;1568-1575.
62. Hukshorn C.J., Saris W.H., Westerterp-Plantenga M.S., Farid A.R., Smith F.J., Campfield L.A. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab. 85:2000;4003-4009. This important study used a long-acting leptin formulation and did not show any weight loss in obese men.
63. Lambert P.D., Anderson K.D., Sleeman M.W., Wong V., Tan J., Hijarunguru A., Corcoran T.L., Murray J.D., Thabet K.E., Yancopoulos G.D., Wiegand S.J. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci USA. 98:2001;4652-4657. Ciliary neurotrophic factor does not play a physiological role in weight regulation but activates similar post-receptor signaling pathways to leptin and appears to be more effective at reducing weight than leptin in animal models. Trials in human obesity are underway.
64. Ziotopoulou M., Erani D.M., Hileman S.M., Bjorbaek C., Mantzoros C.S. Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes. 49:2000;1890-1896.